Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma

BACKGROUND/AIMS: Chronic hepatitis C (CHC) treatment has dramatically improved since direct-acting antiviral (DAA) therapy was introduced. However, the use of DAA therapy in CHC patients with hepatocellular carcinoma (HCC) remains controversial. We investigated the DAA treatment response in CHC pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Korean J Intern Med
Main Authors: Kwan, Byung Soo, Kim, Jeong Han, Park, Seong Jun, Choe, Won Hyeok, Kwon, So Young, Yoo, Byung-Chul
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association of Internal Medicine 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7969069/
https://ncbi.nlm.nih.gov/pubmed/32241083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2019.297
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados